Skip to main content
. 2022 Sep 16;14(9):1961. doi: 10.3390/pharmaceutics14091961

Table 3.

NLC optimization process.

Factors Goal Limits
Solid lipid concn. (% w/v) Maximize 5–10%
Lipid liquid concn. (% p/V) Minimize 3–6%
Surfactant concn. (% w/v) In range 1–2%
Type of solid lipid Equal to Softisan® Softisan® 100,
Gelucire® 44/14
Size (nm) Minimize 24.21–1960
PDI Minimize 0.311–1.000